Trading Signals: ADAP Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Fri. May. 28, 2021)(Adaptimmune Therapeutics plc)
| ADAP latest price $5.0800 (0.99%) ($5.0800 - $5.0800) on Fri. Mar. 5, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.61% (three month average) | RSI | 29 | Latest Price | $5.0800(0.99%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ADAP declines -1.7% a day on average for past five trading days. | Weekly Trend | ADAP declines -9.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ADAP advance at 0% a week (0% probability) JNK(68%) IFRA(40%) IVE(33%) PAVE(29%) HYG(27%) | Factors Impacting ADAP price | ADAP will decline at least -2.305% in a week (0% probabilities). VCIT(-26%) VXX(-18%) TIP(-13%) LQD(-11%) KWEB(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.305% (StdDev 4.61%) | Hourly BBV | -0.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-11.76(-331.5%) | Inflection Point | Yes | Resistance Level | $6.03 | 5 Day Moving Average | $5.31(-4.33%) | 10 Day Moving Average | $5.58(-8.96%) | 20 Day Moving Average | $6.03(-15.75%) | To recent high | -25.7% | To recent low | 1% | Market Cap | $785m | | | | Adaptimmune Therapeutics Plc engages in the development of novel cancer immunotherapy products. Its specific peptide enhanced affinity receptor platform enables the engineering of T-cells to target and destroy cancer, including solid tumors. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom. |